You are here: Industry Insights > Cancer

News List

“Two-pronged” DNA repair attack could kill drug-resistant cancers pharmatimes
March 16, 2020
A new study has suggested that launching a “two-pronged” attack on cancer’s ability to safeguard its DNA could offer an effective new way of treating the disease.
New genetic test could pick out ‘high risk’ bone marrow cancer patients pharmatimes
March 13, 2020
Researchers have developed a new genetic test could help doctors pick out patients with the bone marrow cancer multiple myeloma who are at “ultra high risk” of their cancer progressing aggressively early on.
Low-dose aspirin linked to reduced liver cancer risk worldpharmanews
March 13, 2020
Among adults at high risk of liver cancer, those who took low-dose aspirin were less likely to develop the disease or to die from liver-related causes.
Nanoparticle drug delivery could be the future of targeted cancer therapies europeanpharmaceuticalreview
March 11, 2020
Researchers have created targeted, modifiable nanoparticles which could be combined with pharmaceuticals as a form of drug delivery to treat cancer.
Insight into 2020’s clinical trials landscape europeanpharmaceuticalreview
March 11, 2020
Oncology, industry-sponsored and a combination of the two, will account for the majority of clinical trials categories over the course of the coming year.
Supersensitive smart material developed for targeted drug delivery europeanpharmaceuticalreview
March 11, 2020
Scientists have developed a highly sensitive material that can analyse multiple environmental parameters simultaneously, which could be used in drug delivery.
GSK, Immatics team up for cancer cell therapies pharmatimes
March 10, 2020
Immatics Biotechnologies has announced a new strategic collaboration with GlaxoSmithKline (GSK), in order to develop novel adoptive cell therapies targeting multiple cancer indications.
Gut bacteria can penetrate tumors and aid cancer therapy worldpharmanews
March 10, 2020
Researchers at the University of Texas Southwestern Medical Center and University of Chicago have discovered that bacteria that usually live in the gut can accumulate in tumors and improve the effectiveness of immunotherapy in mice.
Evelo Announces Patent Covering Use of Proprietary Bifidobacterium animalis ssp. lactis Strain americanpharmaceuticalreview
March 06, 2020
Evelo Biosciences announced the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,576,111, entitled “Method of treating cancer using Bifidobacterium animalis ssp.
Harbour BioMed gets FDA nod to begin clinical trial for HBM4003 in cancer pharmaceutical-business-review
March 06, 2020
Harbour BioMed has secured approval from the US Food and Drug Administration (FDA) to move ahead with clinical studies in the US for its anti-CTLA-4 antibody HBM4003 for the treatment of cancer.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page